EORTC-2013-BTG

Back to Clinical Trials Database

Observational study for assessing treatment and outcome of patients with primary brain tumours diagnosed according to cIMPACT-NOW recommendations and the 2021 WHO classification

Study documentation

Trial Status	Recruiting
Dates	Date of activation: 21-Mar-2023
Data management at EORTC	Yes
Design	Cohort Not randomized / N.A.
Targeted Sample size	EORTC Groups: 6000 - All Groups: 6000
Treatment	None
Study Staff	Michael Weller (Study Coordinator) , UniversitaetsSpital Zurich - Neurology Clinic, Zurich Najlaa Alyamani (Clinical Research Physician) , EORTC Headquarters, Brussels Isabelle Blangenois (Clinical Data Expert) , EORTC Headquarters, Brussels Jose Casas (TR Scientist) , EORTC Headquarters, Brussels Corinne Daumer (Project Manager) , EORTC Headquarters, Brussels Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels Lucia Gonzalez (Clinical Operations Manager) , EORTC Headquarters, Brussels Thierry Gorlia (Statistician) , EORTC Headquarters, Brussels Hafida Lmalem (Imaging Officer) , EORTC Headquarters, Brussels Annika Lux (Data Manager) , EORTC Headquarters, Brussels Matthias Preusser (Study Co-Coordinator) , Universitaetsklinikum Wien - AKH unikliniken, Vienna Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Maarten Spruyt (Imaging DM) , EORTC Headquarters, Brussels Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels Eliza Starczewska (Junior RAM) , EORTC Headquarters, Brussels Eliza Starczewska (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Hans-Georg Wirsching (Y-ECI Coordinator) , UniversitaetsSpital Zurich - Neurology Clinic, Zurich
Type of cancer	Brain
Participating groups	EORTC Brain Tumor Group
Recruiting centers	CHU Lyon - Hopital neurologique Pierre Wertheimer (BRON CEDEX, France) Hopital de La Timone (APHM) (MARSEILLE CEDEX 5, France) ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain) IRCCS - Istituto Neurologico Carlo Besta (Milano, Italy) Oslo University Hospital - Radiumhospitalet (Oslo, Norway)
Centers to be activated	A.O Landeskrankenhaus - Innsbruck Universitaetsklinik (Innsbruck, Austria) APHP Sorbonne Univ - Hopital la Pitie-Salpetriere (PARIS, France) AUSL Bologna - Ospedale Bellaria (Bologna, Italy) AZ Delta - Campus Rumbeke (Roeselare, Belgium) Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni - Dipartimento Neuroscienze (Torino, Italy) Azienda Ospedaliero-Universitaria Careggi (Firenze, Italy) Azienda ospedaliero Univ Policlinico Umberto I (Roma, Italy) C.H.U. Sart-Tilman (Liege, Belgium) Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland) Centro Hospitalar Universitario Lisboa Norte - Hospital Sta. Maria (Lisboa, Portugal) Diagnostic & Therapeutic Center of Athens Hygeia Hospital S.A. (Athens, Greece) Erasmus MC (Rotterdam, Netherlands) Hospital Clinic de Barcelona (Barcelona, Spain) Hospital De La Santa Creu I Sant Pau (Barcelona, Spain) ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain) IRCCS - Istituto Oncologico Veneto (Padova, Italy) IRCCS Ospedale San Raffaele (Milano, Italy) IRCCS-Regina Elena National Cancer Center (Roma, Italy) Institut Jules Bordet (Anderlecht, Belgium) Institut de Cancerologie de l’Ouest (ICO) - Saint Herblain (Saint Herblain CEDEX, France) Instituto Portugues de Oncologia de Lisboa Francisco Gentil – EPE (Lisboa, Portugal) Knappschaft Krankenhaus Bochum Langendreer (Bochum-Langendreer, Germany) Leiden University Medical Centre (Leiden, Netherlands) NHS Lothian - The Royal Infirmary Of Edinburgh (Edinburgh, United Kingdom) Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care (Newcastle upon Tyne, United Kingdom) Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom) Onze Lieve Vrouw Ziekenhuis (Aalst, Belgium) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) UMC-Academisch Ziekenhuis Utrecht (Utrecht, Netherlands) UniversitaetsSpital Zurich - Neurology Clinic (Zurich, Switzerland) Universitaetsklinikum - Essen (Essen, Germany) Universitaetsklinikum Bonn (Bonn, Germany) Universitaetsklinikum Jena (Jena, Germany) Universitaetsklinikum Jena (Jena, Germany) Universitaetsklinikum Koeln (Koeln, Germany) Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und Radioonkologie (Leipzig, Germany) Universitaetsklinikum Regensburg (Regensburg, Germany) Universitaetsklinikum Wien - AKH unikliniken (Vienna, Austria) Universitair Ziekenhuis Brussel (Brussels, Belgium) University Hospital Frankfurt -Senckenberg Institute of Neurooncology (Frankfurt am Main, Germany) University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre (Bristol, United Kingdom)
Protocol summary	http://clinicaltrials.gov/ct/show/NCT05259605
NCT number	NCT05259605
Financial Support	EORTC-BTG